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Purpose: Patient exposure to radiation from interventional coronary proce-
dures (ICPs) is high. Dose optimization is in part based on comparison with
reference levels (RLs). Current RLs, however, have been deduced from small
or old multicentre studies. The purpose of this study was to evaluate current
practices for patient radiation protection (RP) in French non-university public
hospitals, which represent >30% of the national activity for ICPs, and 60% of
the emergency cases.
Methods: RAY’ACT was a nationwide, multicentre survey. RP parameters
from 35,257 coronary angiographies (CAs) and 28,604 percutaneous coronary
interventions (PCIs) performed at 48 centres during 2010 and routinely registered
in professional software were extracted and analysed retrospectively. Dose-area
product (DAP), fluoroscopy time (FT), number of acquired frames (NF) and runs
(NR), and cumulative dose to interventional reference point (CD-IRP) were anal-
ysed separately for CAs and PCIs (elective and ad hoc pooled). Emergency and
complex procedures, associated with a high level of radiation, were not excluded.
Results: The table shows the new RLs, based on the 75th percentiles of the
values for CA and PCI, and comparison with previous RLs.
Conclusions: The RAY’ACT survey has allowed the definition of new RLs
for DAP, FT, NF and CD-IRP for CA and PCI, based on a large study popu-
lation. It confirms the trend toward a decrease in radiation doses and FT
during CA. The lack of decrease in DAP and FT during PCI should be inter-
preted according to the likely increase in procedure complexity. 
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Background: Very late stent thrombosis (VLST) is a rare but severe com-
plication of percutaneous coronary intervention. We sought to analyze the
mechanisms involved in the pathophysiology of using optical coherence
tomography (OCT) imaging techniques.
Methods: Patients with an acute coronary syndrome related to VLST from
two catheterization facilities were included in this multicenter registry and
underwent a standard coronary angiography and intra coronary OCT. Unco-
vered strut was defined as a strut of measured neointimal thickness equal to
0 µm. Intra stent neo atherosclerosis (ISNA) was defined as the combination
of neointimal diffuse proliferation, lipid-laden intima with plaque organization
and fibrous cap with no evidence of uncovered strut.
Results: A total of 1539 patients with acute coronary syndromes (ACS)
were admitted in both centers between October 2010 and March 2012. Sixteen
of these subjects (1.03%) presented a definite VLST (drug eluting stents: 38%
of the cases), including n=8 subjects with OCT evidences of ISNA lesions and
n=8 patients with lack of struts neointimal coverage.
We observed that the delay between the initial PCI and the thrombotic
event was longer in ISNA subjects compared to the others (10.1±1.8 vs.
3.9±0.5 y, p=0.01). Moreover, a history of dyslipidemia was more frequent in
the ISNA group (100% vs. 50%, p=0.04) and the mean baseline LDL-choles-
terol value tended to be higher compared to the other group (1.36±0.16 vs.
0.95±0.14 g/l, p=0.07). 
All lesions were treated by initial thrombectomy that was completed by
redo stenting in n=7 ISNA patients (DES in 86% of the cases). No adverse
cardiovascular event (cardiovascular death, reinfarction, urgent PCI or stroke)
was observed during the first 30 days following VLST.
Conclusion: Our data show that ISNA is common in patients with VLST.
These results suggest that OCT imaging is useful to identify the mechanisms
underlying VLST and to help the clinical decision-making process.
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Purpose: Percutaneous coronary intervention (PCI) for Chronic Total
Occlusions (CTO) is associated with a higher failure rate than PCI for other
lesion subsets. The aim of this study was to assess the impact of operator
learning curve on success rate of PCI for CTO.
Methods: The study included consecutive patients undergoing PCI for
CTO at 3 tertiary cardiac centres between January 2004 and December 2011.
To identify minimum case volume for optimum clinical benefit, CTO-PCI
cases were chronologically ranked and stratified into 6 case volume groups, as
1 to 50 (beginner operators), 51 to 100, 101 to 150, 151 to 200, 201 to 250,
>250, for several operators. A multivariable mixed effect logistic regression
for clustered data was used to assess the impact of case volume on PCI failure
after adjustment for patient characteristics, lesion difficulty graded by angio-
graphic score, vessel site, procedural techniques.
Results: A total of 1261 patients, median 63 yrs-old (25th-75th percentile,
55-72), undergoing PCI for 1418 CTO were included. PCI success occurred in
1008 (71%) lesions. Crude success rate was 69.6%, 66.2%, 69.6%, 76.1%,
70.2%, 77.8% across the 6 ordered case volume groups, respectively, p=0.04.
At multivariable logistic regression, increasing case volume across the six cat-
egories was significantly associated with successful PCI (odds ratio (OR)
1.22, 95% confidence interval (CI) 1.13.-1.32, p<0.001). The OR of success
increased substantially and significantly with a case volume of at least 151 to
200, as compared to 1 to 50 case volume (2.09, 95% CI 1.18-3.70, p=0.012),
reaching the highest value in case volume >250 (OR 2.85, 95% CI 1.87-4.34,
p<0.001, while the increase in odds ratio for case volumes < 151, as compared
to 1 to 50 case volume, did not reach the statistical significance.
Conclusions: Operator experience in PCI for CTO is an independent pre-
dictor of success. A minimum case volume >150 is required to increase sig-
nificantly the chance of success compared to beginner operators
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Background: Time-domain optical coherence tomography (TD-OCT) allows
assessment of the anatomy and features of unstable coronary artery lesions,










CA     
N  31,067  672  2,265  496  600
DAP, Gy. cm2  45.2  45  49.4  57  56
FT, min  6.3  8  9  6  7
NF  769  700  1003  1270  876
CD-IRP, mGy  695  650  1900  – –
PCI     
N  25,356  662  1,844  317  600
DAP, Gy. cm2  94.6  85  122  94  110
FT, min  16.2  15  21  16  15
NF  1193  1000  1691  1355  1325
CD-IRP, mGy  1788  1500  2800  – –
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including discrimination between the thrombotic and atherosclerotic plaque com-
ponents. We sought to investigate the feasibility of thrombus quantification and its
monitoring in patients with high thrombotic burden acute coronary syndromes.
Methods: Patients with successfully revascularized acute coronary syn-
dromes and a large thrombus burden on initial coronary angiography who ben-
eficiated from repeated TD-OCT examinations in our institution were suitable
for inclusion. Coronary lesion stenosis degree was determined by quantitative
coronary angiography (QCA) methods. Thrombus volume, maximal surface and
minimal luminal area (MLA) were quantified by serial area measurement within
the athero-thrombotic culprit lesion in 1 mm intervals before any stenting.
Results: Eleven patients underwent 2 consecutive TD-OCT examinations.
The OCT image quality was suitable for thrombus quantification in n=9 subjects
(89% men/ age=62.4±5.7y/ 89% STEMI). All patients were under anticoagulant
and dual antiplatelet therapy between the two procedures (mean delay: 4.1±
0.4 days). No adverse events were observed following OCT analysis.
We measured a progressive reduction of thrombus burden between the two
analysis, as assessed by the decrease of thrombus volume (5.3±1.7
vs.11.0±3.4 mm3, p=0.004), length (7.4±1.0 vs. 10.9±1.8 mm, p=0.02) and
increase of MLA (2.5±0.6 mm2 vs. 1.8±0.3 mm2, p=0.02). However, the
degree of stenosis analyzed by QCA didn’t significantly decrease over time
(49.7±4.6% vs. 55.7±6.6%, p= 0.15). The thrombus volume reduction was
time dependent, as witnessed by the high correlation between the percentage
of thrombus volume decrease and the delay between analysis (R=0.87,
p=0.002). The observed thrombus volume reduction rate was evaluated to
12% of the initial volume per day under medical therapy.
Conclusion: TD-OCT assessment of thrombus volume in patients with
ACS is feasible, safe and could allow in vivo clot regression monitoring.
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Background: We report on the management of and processes of care in
consecutive patients with Takotsubo syndrome using data from a French reg-
istry (OFSETT).
Methods: Between November 2010 and December 2011, 15 non-academic
hospitals included consecutive patients diagnosed with Takotsubo syndrome
according to the Mayo clinic diagnostic criteria.
Results: A total of 121 patients were enrolled: 89% were women and the
mean age was 72±12 years. Most of the women (89%) were >50 years’ old; 8%
of patients had diabetes, 30% were current smokers and 52% had hypertension.
Symptoms of Takotsubo syndrome were chest pain (81%), dyspnoea (27%) and/
or syncope (5%). The mean maximum troponin level was 7.8 ng/mL and the
mean maximum B-type natriuretic peptide level was 1013 pg/mL. ECG showed
a negative T wave in 73%, ST elevation in 42% and/or a new Q wave in 29%
of patients. One patient was treated with fibrinolysis. Coronary angiography was
performed in all patients. Coronary arteries were angiographically normal in
78% of patients and showed <50% stenosis in 22%. Left ventricle (LV) angio-
graphy showed apical ballooning in 35% of patients. The mean LV ejection
fraction was 42±13% on echocardiography and 46±10% on angiography. The
target event was identified in 55% of the patients: mental stress in 61% and
physical stress in 29%. In-hospital treatment included nitrates (11% of patients),
unfractionated heparin (25%), low-molecular-weight heparin (79%), aspirin
(91%), antiplatelets (82%), and angiotensin-converting enzyme inhibitors/angio-
tensin receptor inhibitors (ACE/ARB) (75%). None of the patients died during
hospitalization. At discharge, patients were treated with aspirin (59%), statins
(46%), beta-blockers (75%), ACE/ARB (79%) and/or neurotropic agents (26%).
Conclusion: These observational data from 15 non-academic French hos-
pitals provide insights into the characteristics of patients with Takotsubo syn-
drome and current processes of care for this population.
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Objective: To investigate whether elevated triglycerides and low high-den-
sity lipoprotein (HDL) cholesterol (atherogenic dyslipidemia) are predictive of
risk for silent myocardial ischemia (SMI) or angiographic coronary artery dis-
ease (CAD) in asymptomatic patients with type 2 diabetes.
Methods: Cohort study in 1080 asymptomatic patients with type 2 dia-
betes, a normal 12-lead resting electrocardiogram (ECG), at least one addi-
tional cardiovascular risk factor and low density lipoprotein (LDL) cholesterol
<3.4 mmol/L. Patients initially underwent screening for SMI by 201thallium
myocardial scintigraphy after an ECG stress test, a pharmacological stress test
(dipyridamole injection), or both. Patients with SMI underwent coronary angi-
ography.
Results: SMI was detected in 292 patients and CAD in 91 patients.
Overall, 60 (5.5%) patients had atherogenic dyslipidemia (triglycerides
≥2.04 g/l mmol/L and HDL cholesterol ≤0,34 g/l), which was associated with
SMI (40.0 vs 26.3%, p<0.001) and CAD (22.2 vs 8.3%, p<0.001). In multi-
variate analyses taking into account the parameters associated in univariate
analyses with SMI and then CAD, SMI was associated with atherogenic dys-
lipidemia (odds ratio 1.8[1.0-3.3]), male gender (OR 2.1[1.5-2.9]), BMI (OR
0.97[0.94-1.00]), retinopathy (OR 1.4[1.1-1.9]), peripheral occlusive arterial
disease (POAD: OR 2.5[1.6-3.8]) and mean blood pressure (OR 1.01[1.00-
1.03]); CAD was associated with atherogenic dyslipidemia (OR 4.0[1.7-9.2]),
male gender (OR 3.0[1.6-5.6]), BMI (OR 0.94[0.90-1.00]), retinopathy
(OR 1.7[1.0-2.9], POAD (OR 4.0[2.1-7.4]) and mean blood pressure
(OR 1.03[1.01-1.05]). In the subgroup of 584 patients at LDL cholesterol
<2.6 mmol/L, CAD was also independently associated with atherogenic dys-
lipidemia (2.96 [0.97-9.03], p=0.06).
Conclusions: In type 2 diabetic patients including those at LDL cholesterol
goal, atherogenic dyslipidemia is associated with an increased risk of silent
CAD. Management targeted to this dyslipidemic profile may help to reduce
the high residual burden of cardiovascular disease.
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There are evidences of a link between platelet reactivity inhibition and
thrombotic and bleeding events. We have previously demonstrated that PR
after prasugrel loading dose (LD) predicts short-term thrombotic events. We
aimed to further investigate the relationship between PR under prasugrel and
one-year thrombotic and bleeding events.
Method: Patients were prospectively included in this multicentre study if
they had a successful PCI for an acute coronary syndrome (ACS) and received
prasugrel. Vasodilator-Stimulated Phosphoprotein (VASP index) was mea-
sured after prasugrel LD. Endpoint included the rate of thrombotic events (car-
diovascular death, myocardial infarction and stent thrombosis) and bleeding
events (TIMI) at one year.
